GEAN - Notice of Extraordinary General Meeting
OSLO, NORWAY - 13 September 2021: Notice is hereby served of an extraordinary general meeting of Genetic Analysis AS (the "Company").
The general meeting will be held in the Company's offices in Kabelgata 8, 0580 Oslo on 20 September 2021 at 14:00 hrs.
Please note: Due to the corona pandemic and meeting restrictions, shareholders are urged not to attend the general meeting in person. Shareholders are urged to deliver a proxy. It will be possible to participate at the general meeting electronically through Microsoft Teams. Please refer to further information under the heading "Registration procedures and general information".
Please find attached the notice of the meeting.
For further information, please contact:
Ronny Hermansen, CEO
About Genetic Analysis
Genetic Analysis AS (GA) is a science-based diagnostic company and pioneer in the human microbiome field with more than 10 years of expertise in research and product development. The unique GA-map® platform is based on a pre-targeted multiplex approach specialized for simultaneous analysis of a large number of bacteria in one reaction. The test results are generated by utilizing the clinically validated cutting edge GA-map® software algorithm. This enables immediate results without the need of further bioinformatics work. GA’s vision is to become the leading company for standardized gut microbiota testing worldwide, and GA is committed to help unlocking and restoring the human microbiome through its state-of-the-art technology. GA holds 22 highly qualified employees with relevant scientific backgrounds and with competence in bioinformatics, molecular biology, and bioengineering. www.genetic-analysis.com